Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-572-1 | CAS number: 108-32-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
For propylene carbonate, no experimental in vivo studies are available where absorption, distribution, metabolism and/or excretion are evaluated. Therefore, a qualitative assessment is performed on the basis of the physicochemical properties of the substance, an in vitro hydrolysis/degradation study (Ehmer, 2015) and the publications of Yang et al., (1998) and Hanley et al. (1989). It can be concluded that propylene carbonate hydrolysis in blood is fast and occurred with maximum degradation rates of 0.68 μmol/(ml x min). Under the incubation conditions used in the study, nearly complete hydrolysis and stoichiometric formation of propylene glycol was observed after 5 min.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - oral (%):
- 50
- Absorption rate - dermal (%):
- 50
- Absorption rate - inhalation (%):
- 100
Additional information
Absorption
Oral absorption:
As propylene carbonate is a small molecule (MW 102 g/mol), it will be taken up easily. Moreover, the substance may pass through aqueous pores or be carried through the epithelial barrier by the bulk passage of water. The water-soluble liquid (200 g/L) will readily dissolve into the gastrointestinal fluids. Also the moderate log Kow value is favourable for absorption by passive diffusion. An oral absorption of 50 % is expected.
Respiratory absorption:
As the substance is liquid at room temperature, with a high boiling point (242 °C) and a low vapour pressure (0.06 hPA), no or only a limited number of airborne particles are expected. The substance is water soluble and will be readily soluble in blood. When the substance is airborne, a high amount will be absorbed per breath. Since the substance has a moderate Log KoW (-0.41) absorption might occur. When exposure occurs, 100% respiratory absorption is proposed as a worst case.
Dermal absorption:
The substance is liquid, highly water soluble and relatively small. Moreover, propylene carbonate has a low vapour pressure. These parameters favour dermal uptake. On the other hand, the substance might be too hydrophillic to cross the lipid rich environment of the stratum corneum. Similar to the oral route, an absorption of 50% is expected.
Distribution/Accumulation
Wide distribution throughout the body is expected as the substance is relatively small and water-soluble. It is likely to diffuse through aqueous channels and pores. Based on the results of the (eco)toxicological studies included in this dossier, no bioaccumulation is expected.
Metabolism
In order to demonstrate the metabolism of propylene carbonate, an in vitro hydrolysis study is performed in 2015 (Ehmer B, 2015). The results of the pre-test (Pharmacelsus, 2015) indicate that the hydrolysis of propylene carbonate in rat blood is even faster as compared with ethylene carbonate. Considering that ethylene carbonate was metabolized in vivo to form ethylene glycol and considering that Yang et al. (1998) (here below) showed that alkyl carbonates are hydrolyzed to form CO2and the respective alkyl glycol, it can be concluded that propylene carbonate is hydrolyzed to form propylene glycol.
In the in vitro hydrolysis study, propylene carbonate was incubated in Wistar rat blood over a time span of 30 minutes. There was 5.5 % of the start concentration remaining after 5 minutes of incubation. After 30 minutes 2 out of 3 samples showed quantification results below the limit of quantification. The hydrolysis product propylene glycol was formed simultaneously from the reference item at concentrations that corresponded to its turnover/hydrolysis. The calculated half-life value for propylene carbonate was 0.734 minutes. This corresponds to a turnover of 0.68 μmol/(ml x min). The positive control item ethylene carbonate was also incubated in Wistar rat blood over a time span of 30 minutes. 35.5 % of the start concentration remained after 5 minutes of incubation. After 30 minutes 15.5% of the start concentration was observed. The hydrolysis product ethylene glycol was formed simultaneously from the reference item at concentrations that corresponded to its turnover/hydrolysis. The calculated half-life value for ethylene carbonate was 3.533 minutes. This corresponds to a turnover of 0.14 μmol/(ml x min). These finding indicate that the hydrolysis occurs faster with the propylene carbonate as compared to the positive control. For both compounds the formation of the corresponding glycols was observed simultaneously.
Earlier studies support the abovementioned findings. Hanley et al. (1989) conducted a toxicokinetic study using ethylene carbonate, a structural analogue to propylene carbonate, and demonstrated that the half-life of ethylene carbonate in vivo in rat blood is very short (estimated at 0.25h).
Yang et al. (1998) investigated the biotransformation of certain cyclic alkylene carbonates and demonstrated that these carbonates are hydrolysed to CO2 and the respective alkylene glycol. They tested the hydrolysis of three cyclic carbonates: ethylene carbonate, vinylene carbonate and propylene carbonate. It was confirmed that all three substrates are hydrolysed to CO2 and the respective glycols.
In order to demonstrate the metabolism of propylene carbonate further, an in vitro hydrolysis study is planned. The results of the pre-test (Pharmacelsus, 2015) indicate that the hydrolysis of propylene carbonate in rat blood is even faster as compared with ethylene carbonate. Considering that ethylene carbonate was metabolized in vivo to form ethylene glycol and considering that Yang et al showed that alkyl carbonates are hydrolyzed to form CO2 and the respective alkyl glycol, it can be concluded that propylene carbonate is hydrolyzed to form propylene glycol.
In conclusion, absorbed propylene carbonate is assumed to be metabolised and converted to CO2 and propylene glycol.
Excretion
Based on the physicochemical characteristics of propylene carbonate, excretion via urine is expected, as the substance is relatively small and water soluble.
Hanley et al. (1989) conducted a toxicokinetic study using ethylene carbonate, a structural analogue to propylene carbonate, and demonstrated that ethylene carbonate is primarily excreted via exhalation as carbon dioxide (57%), to a lower amount via the urine (27%) and only marginally via feces (2%).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.